Home > Products > CD64 & HER2
> Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv-Fc)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) (CAT#: BSFVF-128)
Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) is designed to be expressed as a homodimer, which has 2+2 antigen-binding valency. This format consists of one Fc region and two tandem scFv fragments, in which the anti-CD64/HER2 tandem scFv is fused to the Fc domain. The engineered fragment format is used to extend the half-life. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
There are currently no customer reviews or questions for Recombinant Anti-CD64 x Anti-HER2 Bispecific Antibody (Tandem scFv-Fc) (BSFVF-128). Click the button below to contact us or submit your feedback about this product.